Two-Year Outcomes of Surgical Treatment of Severe Ischemic Mitral Regurgitation [1]
2 year outcomes of a randomized trial of MV repair vs MV replacement for severe ischemic MR are reported. LVESVI was similar between the two groups. Recurrent moderate or severe MR was higher in the repair group (59% vs 4%). The repair group suffered higher rates of heart failure and hospital readmission. Mortality rates were not different.
Source name:
New England Journal of Medicine
Resource link:
Subspecialty(ies):
Cardiac [5]
Taxonomy2018 vocabulary term reference: